People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IsoPlexis Corp | — | Other Technology | Series C | $127.0M | $2.3B | 2015 |
| ReNetX Bio, Inc. | — | Biotechnology | Seed | $7.2M | $124.3M | 2019 |
| AtlasXomics Inc. | — | Biotechnology | Seed | $6.2M | $76.4M | 2020 |
| Episteme Prognostics, Inc. | — | Biotechnology | Series A | $4.7M | $2.1M | 2023 |
Gregory Ho at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gregory Ho on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Wagner | 1 | 13 |
| David Wurzer | 1 | 7 |
| James Heath | 1 | 5 |
| John Conley | 1 | 5 |
| David M. Wurzer | 1 | 4 |
| Kenneth Wang | 1 | 4 |
| David I Scheer | 1 | 4 |
| Sharon Kedar | 1 | 3 |
| Michael Egholm | 1 | 3 |
| Jane Henderson | 1 | 2 |
| Sean Mackay | 1 | 2 |
| Sean McKay | 1 | 2 |
| Gregory P Ho | 1 | 2 |
| ERIKA SMITH | 1 | 2 |
| Jason Rifkin | 1 | 2 |
| Robert Warren | 1 | 2 |
| Erika R. Smith | 1 | 1 |
| Amanda Hayward | 1 | 1 |
| Stephen M. Strittmatter | 1 | 1 |
| Sylvia McBrinn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.